Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Type 2 Diabetes Patients With Poor Blood Glucose Control After Diet and Exercise Intervention: a Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study

NCT06575478 is registered in ClinicalTrials.gov with Beijing Supreme Life Pharmaceutical Technology Co., Ltd. as lead sponsor.

NCT NCT06575478
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06575478 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Fuling Yunhua Granules and Dihuang Baoyuan Granules in Type 2 Diabetes Patients With Poor Blood Glucose Control After Diet and Exercise Intervention: a Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Study
Lead sponsor
Beijing Supreme Life Pharmaceutical Technology Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2024
Completion date
January 27, 2025
Enrollment
95 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2, type2diabetes